Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
Authors:
- Peter HagellPHPeter Hagell
- Paola PicciniPPPaola Piccini
- Björn GustaviiBGBjörn Gustavii
- Anders BjörklundABAnders Björklund
Open Access
- 1 July 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Brain
- Vol. 123 (7) , 1380-1390
Abstract
Five parkinsonian patients were transplanted bilaterally into the putamen and caudate nucleus with human embryonic mesencephalic tissue from between seven and nine donors. To increase graft survival, the lipid peroxidation inhibitor tirilazad mesylate was administered to the tissue before implantation and intravenously to the patients for 3 days thereafter. During the second postoperative year, the mean daily L-dopa dose was reduced by 54% and the UPDRS (Unified Parkinson's Disease Rating Scale) motor score in `off' phase was reduced by a mean of 40%. At 10–23 months after grafting, PET showed a mean 61% increase of 6-L-[18F]fluorodopa uptake in the putamen, and 24% increase in the caudate nucleus, compared with preoperative values. No obvious differences in the pattern of motor recovery were observed between these and other previously studied cases with putamen grafts alone. The amount of mesencephalic tissue implanted in each putamen and caudate nucleus was 42 and 50% lower, respectively, compared with previously transplanted patients from our centre. Despite this reduction in grafted tissue, the magnitudes of symptomatic relief and graft survival were very similar. These findings suggest that tirilazad mesylate may improve survival of grafted dopamine neurons in patients, which is in agreement with observations in experimental animals.Keywords
This publication has 42 references indexed in Scilit:
- Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's diseaseMovement Disorders, 2000
- Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson DiseaseArchives of Neurology, 1999
- Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's diseaseAnnals of Neurology, 1997
- Functional Effects of Striatal Dysfunction in Parkinson DiseaseArchives of Neurology, 1997
- Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patientsAnnals of Neurology, 1995
- Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's diseaseAnnals of Neurology, 1995
- Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's diseaseAnnals of Neurology, 1994
- Transplantation of fetal dopamine neurons in Parkinson's disease: PET {18F}6‐L‐fluorodopa studies in two patients with putaminal implantsAnnals of Neurology, 1992
- Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implantsAnnals of Neurology, 1992
- Core assessment program for intracerebral transplantations (CAPIT)Movement Disorders, 1992